Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

NCT07394725 is registered in ClinicalTrials.gov with District Headquarters Teaching Hospital Sahiwal as lead sponsor.

NCT NCT07394725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management
Lead sponsor
District Headquarters Teaching Hospital Sahiwal
Phase
Phase 1
Overall status
Completed
Start date
April 1, 2024
Completion date
March 31, 2025
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-term premature rupture of membranes